Application of accelerated mass spectrometry (AMS) in DNA adduct quantification and identification
- 1 December 1998
- journal article
- Published by Elsevier in Toxicology Letters
- Vol. 102-103, 435-439
- https://doi.org/10.1016/s0378-4274(98)00344-0
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Distribution and metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine (PhIP) in female rats and their pups at dietary dosesCarcinogenesis: Integrative Cancer Research, 1998
- Tissue distribution and macromolecular binding of extremely low doses of [14C]-benzene in B6C3F1 miceCarcinogenesis: Integrative Cancer Research, 1997
- A preliminary evaluation of accelerator mass spectrometry in the biomedical fieldJournal of Pharmaceutical and Biomedical Analysis, 1997
- Dose-response studies of MeIQx in rat liver and liver DNA at low dosesCarcinogenesis: Integrative Cancer Research, 1995
- DNA adducts, mutations and cancerCarcinogenesis: Integrative Cancer Research, 1993
- Significance of DNA adduct studies in animal models for cancer molecular dosimetry and risk assessment.Environmental Health Perspectives, 1993
- Advantages and limitations of laboratory methods for measurement of carcinogen-DNA adducts for epidemiological studiesToxicology Letters, 1992
- The History of AMS, its Advantages over Decay Counting: Applications and ProspectsPublished by Springer Nature ,1992
- Dose-response relationship and low dose extrapolatioin in chemical carcinogenesisCarcinogenesis: Integrative Cancer Research, 1990
- Ultrasensitive radioisotope, stable-isotope, and trace-element analysis in the biological sciences using tandem accelerator mass spectrometryBiological Trace Element Research, 1987